[Federal Register Volume 76, Number 125 (Wednesday, June 29, 2011)]
[Notices]
[Pages 38169-38170]
[FR Doc No: 2011-16183]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPPT-2003-0006; FRL-8872-5]

Toxic Substances Control Act Chemical Testing; Receipt of Test
Data

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces EPA's receipt of test data on five
chemicals listed in the Toxic Substances Control Act (TSCA) section 4
test rule titled ``In Vitro Dermal Absorption Rate Testing of Certain
Chemicals of Interest to the Occupational Safety and Health
Administration,'' amended by the final rule titled ``Revocation of the
TSCA Section 4 Testing Requirements for Certain Chemical Substances.''

FOR FURTHER INFORMATION CONTACT: For technical information contact:
Kathy Calvo, Chemical Control Division (7405M), Office of Pollution
Prevention and Toxics, Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number:
(202) 564-8089; fax number:<PHONE_NUMBER>; e-mail address:
<EMAIL_ADDRESS>    For general information contact: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; e-mail address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    This action is directed to the public in general. This action may,
however, be of interest to those persons who are concerned about data
on health and/or environmental effects and other characteristics of
these chemicals. Since other entities may also be interested, the
Agency has not attempted to describe all the specific entities that may
be affected by this action. If you have any questions regarding the
applicability of this action to a particular entity, consult the person
listed under FOR FURTHER INFORMATION CONTACT.

B. How can I get copies of this document and other related information?

    All documents in the docket are listed in the docket index
available at http://www.regulations.gov. Although listed in the index,
some information is not publicly available, e.g., Confidential Business
Information (CBI) or other information whose disclosure is restricted
by statute. Certain other material, such as copyrighted material, will
be publicly available only in hard copy. Publicly available docket
materials are available electronically at http://www.regulations.gov,
or, if only available in hard copy, at the OPPT Docket. The OPPT Docket
is located in the EPA Docket Center (EPA/DC) at Rm. 3334, EPA West
Bldg., 1301 Constitution Ave., NW., Washington, DC. The EPA/DC Public
Reading Room hours of operation are 8:30 a.m. to 4:30 p.m., Monday
through Friday, excluding legal holidays. The telephone number of the
EPA/DC Public Reading Room is<PHONE_NUMBER>, and the telephone number
for the OPPT Docket is<PHONE_NUMBER>. Docket visitors are required to
show photographic identification, pass through a metal detector, and
sign the EPA visitor log. All visitor bags are processed through an X-
ray machine and subject to search. Visitors will be provided an EPA/DC
badge that must be visible at all times in the building and returned
upon departure.

II. Test Data Submissions

    EPA received test data on five chemicals listed in the TSCA section
4 test rule titled ``In Vitro Dermal Absorption Rate Testing of Certain
Chemicals of Interest to the Occupational Safety and Health
Administration,'' published in the Federal Register issue of April 26,
2004 (69 FR 22402) (FRL-7312-2), and later amended by a final rule
titled ``Revocation of TSCA Section 4 Testing Requirements for Certain
Chemical Substances,'' published in the Federal Register issue of April
12, 2006 (71 FR 18650) (FRL-7751-7).
    Section 4(d) of TSCA (15 U.S.C. 2603(d)) requires EPA to publish a
notice in the Federal Register reporting the receipt of test data
submitted pursuant to test rules promulgated under TSCA section 4(a)
(15 U.S.C. 2603(a)). Each notice must:
    1. Identify the chemical substance or mixture for which data have
been received.
    2. List the uses or intended uses of such substance or mixture and
the information required by the applicable standards for the
development of test data.
    3. Describe the nature of the test data developed.
    The following table contains the information described in this
document. See the applicable CFR cite, listed in the table, for test
data requirements. EPA has completed its review and evaluation process
for these submissions. The reviews have been added to the docket.

   Table 1--Data Received in Response to TSCA Section 4 Test Rule at 40 CFR 799.5115, Titled ``In Vitro Dermal
Absorption Rate Testing of Certain Chemicals of Interest to the Occupational Safety and Health Administration,''
                                     Docket ID Number EPA-HQ-OPPT-2003-0006
----------------------------------------------------------------------------------------------------------------
                                                                     Document No. for
                                                                       the item in
           Chemical identity                   Data received        docket No. EPA-HQ-        Chemical use
                                                                      OPPT-2003-0006
----------------------------------------------------------------------------------------------------------------
Vinylidene chloride (Ethene, 1,1-        Vinylidene Chloride: In                0354   Copolymerized with vinyl
 dichloro-) (CASRN 75-35-4).              Vitro Dermal Absorption                       chloride or
                                          Rate Testing.                                 acrylonitrile to form
                                                                                various kinds of saran,
                                                                                other copolymers are
                                                                                also made, adhesives,
                                                                                component of synthetic
                                                                                fibers.

Dicyclopentadiene......................  Percutaneous Absorption                0358   Chemical intermediate for
(4,7-Methano-1H-indene, 3a,4,7,7a-        and Cutaneous                                 insecticides, ethylene
 tetrahydro-) (CASRN 77-73-6).            Disposition of [\14\C]-                       propylene diene monomer
                                          Dicyclopentadiene In                          (EPDM) elastomers,
                                          Vitro in Human Skin.                          metallocenes, paints and
                                                                                varnishes, flame
                                                                                retardant for plastics.
Methyl isoamyl ketone..................  Percutaneous Absorption                0359   Solvent for
(2-Hexanone, 5-methyl-) (CASRN 110-12-    and Cutaneous                                 nitrocellulose,
 3).                                      Disposition of [\14\C]-                       cellulose acetate
                                          Methyl Isoamyl Ketone In                      butyrate, acrylics,
                                          Vitro in Human Skin.                          vinyl copolymers.
Diacetone alcohol......................  Percutaneous Absorption                0360   Solvent for
(2-Pentanone, 4-hydroxy-4-methyl-)        and Cutaneous                                 nitrocellulose,
 (CASRN 123-42-2).                        Disposition of [\14\C] -                      cellulose acetate,
                                          Diacetone Alcohol In                          various oils, resins,
                                          Vitro in Human Skin.                          waxes, fats, dyes, tars,
                                                                                lacquers, dopes, coating
                                                                                compositions, wood
                                                                                preservatives, stains,
                                                                                rayon and artificial
                                                                                leather, imitation gold
                                                                                leaf, dyeing mixtures,
                                                                                antifreeze mixtures,
                                                                                extraction of resins and
                                                                                waxes, preservative for
                                                                                animal tissue, metal-
                                                                                cleaning compounds,
                                                                                hydraulic compression
                                                                                fluids, stripping agent
                                                                                (textiles), laboratory
                                                                                reagent. The technical
                                                                                grade containing acetone
                                                                                has greater solvent
                                                                                power.
Cyclohexanol (CASRN 108-93-0)..........  The In Vitro Dermal                    0371   Soap making to
                                          Absorption of \14\C-                          incorporate solvents and
                                          Cyclohexanol through                          phenolic insecticides;
                                          Human Skin.                                   source of adiptic acid
                                                                                for nylon textile
                                                                                finishing; solvent for
                                                                                alkyd and phenotic
                                                                                resins; cellulosics;
                                                                                blending agent for
                                                                                lacquers, paints, and
                                                                                varnishes; finish
                                                                                removers; emulsified
                                                                                products; leather
                                                                                degreasing; polishes;
                                                                                plasticizers; plastics;
                                                                                germicides.
----------------------------------------------------------------------------------------------------------------
Note: CASRN--Chemical Abstract Service Registry Number; Chemical Use Reference--Hawley's Condensed Chemical
  Dictionary. Fifteenth Ed. Richard J. Lewis, Sr. Published by John Wiley & Sons, Inc., Hoboken, NJ. 2007.

    Authority: 15 U.S.C. 2603.

List of Subjects

    Environmental protection, Hazardous substances.

    Dated: June 21, 2011.
Maria J. Doa,
Director, Chemical Control Division, Office of Pollution Prevention and
Toxics.
[FR Doc. 2011-16183 Filed 6-28-11; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register: November 18, 2008 (Volume 73, Number 223)]
[Notices]
[Page 68464-68465]
[DOCID:fr18no08-123]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-58924; File No. SR-CBOE-2008-96]

Self-Regulatory Organizations; Chicago Board Options Exchange,
Incorporated; Order Granting Approval of Proposed Rule Change To Permit
$1 Strikes for MNX Options

November 10, 2008.

I. Introduction

    On September 16, 2008, the Chicago Board Options Exchange,
Incorporated (``CBOE'' or ``Exchange'') filed with the Securities and
Exchange Commission

(``Commission''), pursuant to Section 19(b)(1) of the Securities
Exchange Act of 1934 (``Act'')\1\ and Rule 19b-4 thereunder,\2\ this
proposed rule change. The proposed rule change was published for
comment in the Federal Register on October 8, 2008.\3\ The Commission
received no comments on the proposal. This order approves the proposed
rule change.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ See Securities Exchange Act Release No. 58659 (September 26,
2008), 73 FR 58998 (``Notice'').
---------------------------------------------------------------------------

II. Description of the Proposal

    The proposed rule change amends Rule 24.9, Terms of Index Option
Contracts, by adding a new interpretation that will allow the Exchange
to list options on the Mini-Nasdaq-100 Index (``MNX'' or ``Mini-NDX''),
which is based on \1/10\th the value of the Nasdaq-100 Index, at $1 or
greater strike price intervals.\4\ For initial series, the Exchange
will be able to list at least two strike prices above and two strike
prices below the current value of the MNX at or about the time a series
is opened for trading on the Exchange. As part of this initial listing,
the Exchange will be able to list strike prices that are within five
points from the closing value of the MNX on the preceding day.
---------------------------------------------------------------------------

    \4\ Currently, under Interpretation and Policy .01(a)(xxv) to
Rule 24.9, the Exchange has authority to list Mini-NDX options at
$2.50 strike price intervals. The Commission notes that the Exchange
rules currently allow the Exchange to list series at $1 or greater
strike price intervals in similar options products. For example,
Rule 24.9.01(b) allows the Exchange to list series on options based
on one-one hundredth (1/100th) of the value of the Dow Jones
Industrial Average Index at no less than $0.50 intervals. Similarly,
Rule 24.9.01(f) allows the Exchange to list strike price intervals
at no less than $1 for options on the CBOE S&P 500 BuyWrite Index
(1/10th value). In addition, Rule 24.9.11 allows the Exchange to
list strike price intervals at no less than $1 for the reduced-value
version of the Standard & Poor's S&P 500 Stock Index option (``Mini-
SPX option''), which is based on 1/10th the value of the S&P 500
Index. See Securities Exchange Act Release Nos. 39011 (September 3,
1997), 62 FR 47840 (September 11, 1997); 58207 (July 29, 2008), 73
FR 43963 (July 22, 2008); 52625 (October 18, 2005), 70 FR 61479
(October 24, 2005); and 57049 (December 27, 2007), 73 FR 528
(January 3, 2008).
---------------------------------------------------------------------------

    The Exchange will be permitted to list additional series when the
Exchange deems it necessary to maintain an orderly market, to meet
customer demand, or when the underlying MNX moves substantially from
the initial exercise price or prices. To the extent that any additional
strike prices are listed by the Exchange, such additional strike prices
shall be within thirty percent (30%) above or below the closing value
of the MNX. The Exchange also will be permitted to open additional
strike prices that are more than 30% above or below the current MNX
value provided that demonstrated customer interest exists for such
series, as expressed by institutional, corporate or individual
customers or their brokers. Market-Makers trading for their own account
will not be considered when determining customer interest. In addition
to the initial listed series, the Exchange may list up to sixty (60)
additional series per expiration month for each series in Mini-NDX
options. The Exchange proposes that it shall not list LEAPS on Mini-NDX
options at intervals less than $5.
    The Exchange also is proposing to set forth a delisting policy with
respect to Mini-NDX options. The Exchange will, on a monthly basis,
review series that are outside a range of five (5) strikes above and
five (5) strikes below the current value of the MNX and delist series
with no open interest in both the put and the call series having a: (i)
Strike higher than the highest strike price with open interest in the
put and/or call series for a given expiration month; and (ii) strike
lower than the lowest strike price with open interest in the put and/or
call series for a given expiration month. Notwithstanding the proposed
delisting policy, customer requests to add strikes and/or maintain
strikes in Mini-NDX options in series eligible for delisting shall be
granted.

III. Commission's Findings and Order Granting Approval of the Proposed
Rule Change

    After careful review, the Commission finds that the proposed rule
change is consistent with the requirements of the Act and the rules and
regulations thereunder applicable to a national securities exchange.\5\
In particular, the Commission finds that the proposed rule change is
consistent with Section 6(b)(5) of the Act \6\ in that it is designed
to promote just and equitable principles of trade, to prevent
fraudulent and manipulative acts, and, in general, to protect investors
and the public interest.
---------------------------------------------------------------------------

    \5\ In approving this proposed rule change, the Commission notes
that it has considered the proposed rule's impact on efficiency,
competition, and capital formation. See 15 U.S.C. 78c(f).
    \6\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

    Specifically, the Commission believes that the proposal to permit
listing of $1 strike prices for Mini-NDX options will provide investors
with added flexibility in the trading of Mini-NDX options and further
the public interest by allowing investors to establish positions that
are better tailored to meet their investment objectives. The Commission
also believes that the proposal strikes a reasonable balance between
the Exchange's desire to accommodate market participants by offering a
wider array of investment opportunities and the need to avoid
unnecessary proliferation of options series and the corresponding
increase in quotes. The Commission notes that the existing restrictions
on listing $1 strike price intervals will continue to apply, e.g., no
$1 strike price may be listed (a) that is greater than $5 from MNX's
closing price on the preceding day, or (b) that would result in strike
prices being $0.50 apart.
    In approving the proposed rule change, the Commission has relied on
the Exchange's representation that it has the necessary systems
capacity to support the new options series that will be listed under
this proposal. The Commission expects the Exchange to continue to
monitor for options with little or no open interest and trading
activity and to act promptly to delist such options. In addition, the
Commission expects that CBOE will continue to monitor the trading
volume associated with the additional options series listed as a result
of this proposal and the effect of these additional series on market
fragmentation and on the capacity of the Exchange's, OPRA's, and
vendors' automated systems.

IV. Conclusion

    It is therefore ordered, pursuant to Section 19(b)(2) of the
Act,\7\ that the proposed rule change (SR-CBOE-2008-96) be, and it
hereby is, approved.
---------------------------------------------------------------------------

    \7\ 15 U.S.C. 78s(b)(2).
    \8\ 17 CFR 200.30-3(a)(12).

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\8\
Florence E. Harmon,
Acting Secretary.
[FR Doc. E8-27280 Filed 11-17-08; 8:45 am]

BILLING CODE 8011-01-P


[Federal Register Volume 78, Number 196 (Wednesday, October 9, 2013)]
[Notices]
[Pages 61985-61986]
[FR Doc No: 2013-24408]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CD13-6-000]

City of Astoria, Oregon; Notice of Preliminary Determination of a
Qualifying Conduit Hydropower Facility and Soliciting Comments and
Motions To Intervene

    On September 24, 2013, City of Astoria, Oregon (Astoria) filed a
notice of intent to construct a qualifying conduit hydropower facility,
pursuant to section 30 of the Federal Power Act, as amended by section
4 of the Hydropower Regulatory Efficiency Act of 2013 (HREA). The 60 kW
Bear Creek Watershed Hydroelectric Project would utilize the city of
Astoria's water distribution system, and it would be located in Clatsop
County, Oregon.
    Applicant Contact: Paul Benoit, City of Astoria, Oregon, 1095 Duane
Street, Astoria, OR 97103, Phone No.<PHONE_NUMBER>.
    FERC Contact: Robert Bell, Phone No.<PHONE_NUMBER>, email:
<EMAIL_ADDRESS>    Qualifying Conduit Hydropower Facility Description: The proposed
project would consist of the following two developments:
    Site one would consist of: (1) A new intake pipeline receiving
water from an existing 26-inch conduit pipeline; (2) a new powerhouse
containing one new 30-kilowatt generating unit; (3) a new, small
pipeline discharging water into an existing 21-inch pipeline; and (4)
appurtenant facilities.
    Site two would consist of: (1) A new intake pipeline receiving
water from an existing 21-inch conduit pipeline; (2) an existing
powerhouse containing one new 30-kilowatt generating unit; (3) a new,
small pipeline discharging water into an existing 21-inch pipeline; and
(4) appurtenant facilities.
    The proposed project would have an estimated annual generating
capacity of 175.25 megawatt-hours.
    A qualifying conduit hydropower facility is one that is determined
or deemed to meet all of the criteria shown in the table below.

                          Table 1--Criteria for Qualifying Conduit Hydropower Facility
----------------------------------------------------------------------------------------------------------------
                                                                                Satisfies
            Statutory provision                                   Description                           (Y/N)
----------------------------------------------------------------------------------------------------------------
FPA 30(a)(3)(A), as amended by HREA.......  The conduit the facility uses is a tunnel, canal,                 Y
                                             pipeline, aqueduct, flume, ditch, or similar manmade
                                             water conveyance that is operated for the
                                             distribution of water for agricultural, municipal, or
                                             industrial consumption and not primarily for the
                                             generation of electricity.
FPA 30(a)(3)(C)(i), as amended by HREA....  The facility is constructed, operated, or maintained              Y
                                             for the generation of electric power and uses for
                                             such generation only the hydroelectric potential of a
                                             non-federally owned conduit.
FPA 30(a)(3)(C)(ii), as amended by HREA...  The facility has an installed capacity that does not              Y
                                             exceed 5 megawatts.
FPA 30(a)(3)(C)(iii), as amended by HREA..  On or before August 9, 2013, the facility is not                  Y
                                             licensed, or exempted from the licensing requirements
                                             of Part I of the FPA.
----------------------------------------------------------------------------------------------------------------

    Preliminary Determination: Based upon the above criteria,
Commission staff preliminarily determines that the proposal satisfies
the requirements for a qualifying conduit hydropower facility not
required to be licensed or exempted from licensing.
    Comments and Motions To Intervene: Deadline for filing comments
contesting whether the facility meets the qualifying criteria is 45
days from the issuance date of this notice.
    Deadline for filing motions to intervene is 30 days from the
issuance date of this notice.
    Anyone may submit comments or a motion to intervene in accordance
with the requirements of Rules of Practice and Procedure, 18 CFR
385.210 and 385.214. Any motions to intervene must be received on or
before the specified deadline date for the particular proceeding.
    Filing and Service of Responsive Documents: All filings must (1)
bear in all capital letters the ``COMMENTS CONTESTING QUALIFICATION FOR
A CONDUIT HYDROPOWER FACILITY'' or ``MOTION TO INTERVENE,'' as
applicable; (2) state in the heading the name of the applicant and the
project number of the application to which the filing responds; (3)
state the name, address, and telephone number of the person filing; and
(4) otherwise comply with the requirements of sections 385.2001 through
385.2005 of the Commission's regulations.\1\ All comments contesting
Commission staff's preliminary determination that the facility meets
the qualifying criteria must set forth their evidentiary basis.
---------------------------------------------------------------------------

    \1\ 18 CFR 385.2001-385.2005 (2013).
---------------------------------------------------------------------------

    The Commission strongly encourages electronic filing. Please file
motions to intervene and comments using the Commission's eFiling system
at http://www.ferc.gov/docs-filing/efiling.asp. Commenters can submit
brief comments up to 6,000 characters, without prior registration,
using the eComment system at http://www.ferc.gov/docs-filing/ecomment.asp. You must include your name and contact information at the
end of your comments. For assistance, please contact FERC Online
Support at<EMAIL_ADDRESS>(866) 208-3676 (toll free), or
(202) 502-8659 (TTY). In lieu of electronic filing, please

send a paper copy to: Secretary, Federal Energy Regulatory Commission,
888 First Street NE., Washington, DC 20426. A copy of all other filings
in reference to this application must be accompanied by proof of
service on all persons listed in the service list prepared by the
Commission in this proceeding, in accordance with 18 CFR 4.34(b) and
385.2010.
    Locations of Notice of Intent: Copies of the notice of intent can
be obtained directly from the applicant or such copies can be viewed
and reproduced at the Commission in its Public Reference Room, Room 2A,
888 First Street NE., Washington, DC 20426. The filing may also be
viewed on the Web at http://www.ferc.gov/docs-filing/elibrary.asp using
the ``eLibrary'' link. Enter the docket number (e.g., CD13-6-000) in
the docket number field to access the document. For assistance, call
toll-free 1-866-208-3676 or email<EMAIL_ADDRESS>For TTY,
call<PHONE_NUMBER>.

    Dated: October 2, 2013.
Kimberly D. Bose,
Secretary.
[FR Doc. 2013-24408 Filed 10-8-13; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 82, Number 117 (Tuesday, June 20, 2017)]
[Proposed Rules]
[Pages 28040-28041]
[FR Doc No: 2017-12839]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 312

[EPA-HQ-OLEM-2016-0786; FRL-9958-46-OLEM]

Amendment to Standards and Practices for All Appropriate
Inquiries Under CERCLA

AGENCY: Environmental Protection Agency (EPA).

ACTION: Proposed rule.

-----------------------------------------------------------------------

SUMMARY: EPA is proposing to amend the Standards and Practices for All
Appropriate Inquiries to update an existing reference to a standard
practice recently made available by ASTM International, a widely
recognized standards development organization. Specifically, EPA is
proposing to amend the All Appropriate Inquiries Rule to reference ASTM
International's E2247-16 ``Standard Practice for Environmental Site
Assessments: Phase I Environmental Site Assessment Process for
Forestland or Rural Property'' and allow for its use to satisfy the
statutory requirements for conducting all appropriate inquiries under
the Comprehensive Environmental Response, Compensation and Liability
Act (CERCLA). In the ``Rules and Regulations'' section of this Federal
Register, EPA is amending the All Appropriate Inquiries Rule to
reference the ASTM E2247-16 Standard as a direct final rule without a
prior proposed rule. If we receive no adverse comment, we will not take
further action on this proposed rule.

DATES: Written comments must be received by July 20, 2017.

ADDRESSES: Submit your comments, identified by Docket ID No. EPA-HQ-
OLEM-2016-0786 at http://www.regulations.gov. Follow the online
instructions for submitting comments. Once submitted, comments cannot
be edited or removed from Regulations.gov. The EPA may publish any
comment received to its public docket. Do not submit electronically any
information you consider to be Confidential Business Information (CBI)
or other information whose disclosure is restricted by statute.
Multimedia submissions (audio, video, etc.) must be accompanied by a
written comment. The written comment is considered the official comment
and should include discussion of all points you wish to make. The EPA
will generally not consider comments or comment contents located
outside of the primary submission (i.e. on the web, cloud, or other
file sharing system). For additional submission methods, the full EPA
public comment policy, information about CBI or multimedia submissions,
and general guidance on making effective comments, please visit https://www.epa.gov/dockets/commenting-epa-dockets.

FOR FURTHER INFORMATION CONTACT: For general information, contact the
CERCLA Call Center at<PHONE_NUMBER> or TDD<PHONE_NUMBER> (hearing
impaired). In the Washington, DC metropolitan

area, call<PHONE_NUMBER> or TDD<PHONE_NUMBER>. For more detailed
information on specific aspects of this rule, contact Patricia
Overmeyer, Office of Brownfields and Land Revitalization (5105T), U.S.
Environmental Protection Agency, 1200 Pennsylvania Avenue NW.,
Washington, DC 20460-0002,<PHONE_NUMBER>, or<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Why is EPA using this proposed rule?

    This document proposes an amendment to 40 Code of Federal
Regulations (CFR) part 312. In the ``Rules and Regulations'' section of
this Federal Register, EPA is making these changes as a direct final
rule without a prior proposed rule because we view this as a
noncontroversial action and anticipate no adverse comment. We have
explained our reasons for this action, including our reasons for the
specific amendment, in the preamble to the direct final rule.
Additionally, the amendment to the regulatory text for this proposed
rule can also be found in the direct final rule. If we receive no
adverse comment on any of the changes we are promulgating today, we
will not take further action on this proposed rule. If, however, we
receive such comment, we will publish a timely withdrawal in the
Federal Register informing the public that this amendment will not take
effect, and the reason for such withdrawal. We do not intend to
institute a second comment period on this action. Any parties
interested in commenting must do so at this time. EPA will address
public comments in any subsequent final rule. For further information,
please see the information provided in the ADDRESSES section of this
document.

II. Does this action apply to me?

    The discussion of the potentially affected entities by this
proposed rule can be found in the preamble to the direct final rule.

III. Statutory and Executive Order Reviews

    For a complete discussion of all the administrative requirements
applicable to this action, see the direct final rule in the ``Rules and
Regulations'' section of this Federal Register.

List of Subjects in 40 CFR Part 312

    Environmental Protection, Administrative practice and procedure,
Hazardous substances, Intergovernmental relations, Reporting and
recordkeeping requirements, Superfund.

    Dated: June 12, 2017.
Barry N. Breen,
Acting Assistant Administrator, Office of Land and Emergency
Management.
[FR Doc. 2017-12839 Filed 6-19-17; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 76, Number 160 (Thursday, August 18, 2011)]
[Notices]
[Pages 51373-51374]
[FR Doc No: 2011-21041]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0402]

Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; State Petitions for
Exemption From Preemption

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.

DATES: Fax written comments on the collection of information by
September 19, 2011.

ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
Fax:<PHONE_NUMBER>, or e-mailed to<EMAIL_ADDRESS>All
comments should be identified with the OMB control number 0910-0277.
Also include the FDA docket number found in brackets in the heading of
this document.

FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of
Information Management, Food and Drug Administration, 1350 Piccard Dr.,
PI50-400B, Rockville, MD 20850,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.

State Petitions for Exemption From Preemption--21 CFR 100.1(d) (OMB
Control Number 0910-0277)--Extension

    Under section 403A(b) of the Federal Food, Drug, and Cosmetic Act
(the FD&C Act) (21 U.S.C. 343-1(b)), States may petition FDA for
exemption from Federal preemption of State food labeling and standard
of identity requirements. Section 100.1(d) (21 CFR 100.1(d)) sets forth
the information a State is required to submit in such a petition. The
information required under Sec.  100.1(d) enables FDA to determine
whether the State food labeling or standard of identity requirement
satisfies the criteria of section 403A(b) of the FD&C Act for granting
exemption from Federal preemption.
    In the Federal Register of June 10, 2011 (76 FR 34082), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. No comments were received.
    FDA estimates the burden of this collection of information as
follows:

                                 Table 1--Estimated Annual Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
                                                     Number of                        Average
         21 CFR section              Number of     responses per   Total annual     burden per      Total hours
                                    respondents     respondent       responses       response
----------------------------------------------------------------------------------------------------------------
100.1(d)........................               1               1               1              40              40
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.

    The reporting burden for Sec.  100.1(d) is minimal because
petitions for exemption from preemption are seldom submitted by States.
In the last 3 years, FDA has not received any new petitions for
exemption from preemption; therefore, the Agency estimates that one or
fewer petitions will be submitted annually. Although FDA has not
received any new petitions for exemption from preemption in the last 3
years, it believes these information collection provisions should be
extended to provide for the potential future need of a State or local

government to petition for an exemption from preemption under the
provisions of section 403A of the FD&C Act.

    Dated: August 12, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-21041 Filed 8-17-11; 8:45 am]
BILLING CODE 4160-01-P


[Federal Register: December 4, 2007 (Volume 72, Number 232)]
[Notices]
[Page 68138-68139]
[DOCID:fr04de07-49]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP07-208-000]

Rockies Express Pipeline, LLC; Notice of Availability of the
Draft Environmental Impact Statement for the Proposed REX East Project

November 23, 2007.
    The staff of the Federal Energy Regulatory Commission (FERC or
Commission) has prepared this draft Environmental Impact Statement
(EIS) for the construction and operation of the natural gas pipeline
facilities proposed by Rockies Express Pipeline LLC (Rockies Express)
in the above-referenced docket. The Project facilities would be located
in Wyoming, Nebraska, Missouri, Illinois, Indiana, and Ohio.
    This draft EIS was prepared to satisfy the requirements of the
National Environmental Policy Act (NEPA). The U.S. Army Corps of
Engineers, U.S. Fish and Wildlife Service, Natural Resources
Conservation Service, and Illinois Department of Agriculture are
cooperating agencies for the development of the EIS. A cooperating
agency has jurisdiction by law or special expertise with respect to
potential environmental impacts associated with the proposal and is
involved in the NEPA analysis.
    The FERC staff concludes that if the Project is constructed and
operated in accordance with applicable laws and regulations, and the
project sponsor's proposed mitigation, and the staff's additional
mitigation recommendations, it would have mostly limited adverse
environmental impacts and would be an environmentally acceptable
action.
    As currently proposed, the Rockies Express (REX) East Project would
consist of the construction and operation of approximately 639.1 miles
of natural gas pipeline and a total of 225,716 horsepower (hp) of new
compression. The REX East Project would be part of the Rockies Express
Pipeline System--a 1,679-mile natural gas pipeline system that would
extend from Colorado to Ohio. The Project pipeline would deliver up to
1.8 billion cubic feet per day of gas to other interstate natural gas
pipelines. The Project would provide access to an additional 16 inter-
and intra-state natural gas pipelines at 20 interconnect points.
Specifically, the draft EIS addresses the potential environmental
effects of the construction and operation of the following natural gas
pipeline facilities proposed by Rockies Express:
     639.1 miles of 42-inch-diameter natural gas pipeline in
Missouri, Illinois, Indiana, and Ohio;
     Seven new compressor stations (Mexico Compressor Station
in Audrain County, Missouri; Blue Mound Compressor Station in Christian
County, Illinois; Bainbridge Compressor Station in Putnam County,
Indiana; Hamilton Compressor Station in Butler County, Ohio;
Chandlersville Compressor Station in Muskingum County, Ohio; Arlington
Compressor Station in Carbon County, Wyoming; and Bertrand Compressor
Station in Phelps County, Nebraska; and
     20 meter stations and associated interconnecting pipeline
facilities at 13 locations along the proposed pipeline route and 42
mainline valves.

Comment Procedures and Public Meetings

    Any person wishing to comment on the draft EIS may do so. To ensure
consideration prior to a Commission decision on the proposal, it is
important that the Commission receive your comments before the date
specified below. Please carefully follow these instructions to ensure
that your comments are received and properly recorded:
     Send an original and two copies of your comments to:
Kimberly D. Bose, Secretary, Federal Energy Regulatory Commission, 888
First Street, NE., Room 1A, Washington, DC 20426.
     Reference Docket No. CP07-208-000.
     Label one copy of the comments for the attention of Gas
Branch 2.
     Mail your comments so that they will be received in
Washington, DC on or before January 14, 2008.
    The Commission strongly encourages electronic filing of any
comments, interventions or protests to this proceeding. See 18 Code of
Federal Register (CFR) 385.2001(a)(1)(iii) and the instructions on the
Commission's Internet Web site (http://www.ferc.gov) under the ``e-

Filing'' link and the link to the User's Guide. Before you can submit
comments, you will need to create a free account, by clicking on
``Sign-up'' under ``New User.'' You will be asked to select the type of
submission you are making. This type of submission is considered a
``Comment on Filing.'' Comments submitted electronically must be
submitted by January 14, 2008.
    In lieu of sending written comments, you are invited to attend
public comment meetings the FERC has scheduled as follows:

January 7, 2008 6 p.m. to 10 p.m.
    Lanphier High School, 1300 N 11th Street, Springfield, IL 62702,
(217) 525-3080
    Clark's Hall Reception Area, 2155 E U.S. Highway 36, Rockville, IN
47872,<PHONE_NUMBER>
    Zanesville High School, 1701 Blue Avenue, Zanesville, OH 43701,
(740) 588-4203
January 8, 2008 6 p.m. to 10 p.m.
    Pittsfield High School, 201 E Higbee Street, Pittsfield, IL 62363,
(217) 285-6888
    Greensburg Jr. High School, 505 E Central Ave, Greensburg, IN
47240,<PHONE_NUMBER>

    Teays Valley High School, 3887 St. Route 752, Ashville, OH 43103,
(740) 983-3131
January 9, 2008 6 p.m. to 10 p.m.
    Presser Hall, 900 South Jefferson Street, Mexico, MO, (573) 581-
5592
    Greenwood Community High School, 615 W Smith Valley Road,
Greenwood, IN 46142,<PHONE_NUMBER>
    Edgwood High School, 5005 Oxford State Rd, Trenton, OH 45067, (513)
867-7425

    Interested groups and individuals are encouraged to attend and
present oral comments on the draft EIS. Transcripts of the meetings
will be prepared.
    After the comments are reviewed, any significant new issues are
investigated, and modifications are made to the draft EIS, a final EIS
will be published and distributed by the FERC staff. The final EIS will
contain the staff's responses to timely comments received on the draft
EIS.
    Comments will be considered by the Commission and cooperating
agencies but will not serve to make the commentor a party to the
proceeding. Any person seeking to become a party to the proceeding must
file a motion to intervene pursuant to Rule 214 of the Commission's
Rules of Practice and Procedures (18 CFR 385.214). Anyone may intervene
in this proceeding based on this draft EIS. Only intervenors have the
right to seek rehearing of the Commission's decision. You must file
your request to intervene as specified above.\1\ You do not need
intervenor status to have your comments considered.
---------------------------------------------------------------------------

    \1\ Interventions may also be filed electronically via the
Internet in lieu of paper. See the previous discussion on filing
comments electronically.
---------------------------------------------------------------------------

    The draft EIS has been placed in the public files of the FERC and
is available for distribution and public inspection at:
    Federal Energy Regulatory Commission, Public Reference Room, 888
First Street, NE., Room 2A, Washington, DC 20426,<PHONE_NUMBER>.
    A limited number of hardcopies and CD-ROMs of the draft EIS are
available from the FERC's Public Reference Room, identified above. This
draft EIS is also available for public viewing on the FERC's Internet
Web site at http://www.ferc.gov. CD-ROM copies of the draft EIS have

been mailed to Federal, State, and local agencies; public interest
groups; individuals and affected landowners who requested a copy of the
draft EIS or provided comments during scoping; libraries and newspapers
in the Project area; and parties to this proceeding. Hard copy versions
of the draft EIS were mailed to those specifically requesting them.
    Additional information about the project is available from the
Commission's Office of External Affairs, at 1-866-208-FERC or on the
FERC Internet Web site (http://www.ferc.gov) using the eLibrary link.

Click on the eLibrary link, click on ``General Search'' and enter the
docket number excluding the last three digits in the Docket Number
(e.g. CP07-208). Be sure you have selected an appropriate date range.
For assistance, please contact FERC Online Support at
<EMAIL_ADDRESS>or toll free at 1-866-208-3676, or for TTY,

contact<PHONE_NUMBER>. The eLibrary link on the FERC Internet Web site
also provides access to the texts of formal documents issued by the
Commission, such as orders, notices, and rulemakings.
    In addition, the Commission now offers a free service called
eSubscription which allows you to keep track of all formal issuances
and submittals in specific dockets. This can reduce the amount of time
you spend researching proceedings by automatically providing you with
notification of these filings, document summaries, and direct links to
the documents. Go to the eSubscription link on the FERC Internet Web
site.

Kimberly D. Bose,
Secretary.
[FR Doc. E7-23445 Filed 12-3-07; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 83, Number 147 (Tuesday, July 31, 2018)]
[Notices]
[Pages 36924-36925]
[FR Doc No: 2018-16357]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. EL18-188-000]

NRG Curtailment Solutions, Inc. v. New York Independent System
Operator; Notice of Complaint

    Take notice that on July 24, 2018, pursuant to sections 206 and 306
of the Federal Power Act, 16 U.S.C. 824e and 825e and Rule 206 of the
Federal Energy Regulatory Commission's (Commission) Rules of Practice
and Procedure, 18 CFR 385.206, NRG Curtailment Solutions, Inc.
(Complainant) filed a formal complaint against New York Independent
System Operator (Respondent) alleging that, Respondent's rules that
Curtailment Service Providers and Responsible Interface Parties must be
certified by the New York Department of Public Service is unjust and
unreasonable, all as more fully explained in the complaint.

    The Complainant certifies that copies of the complaint were served
on the contacts for the Respondent as listed on the Commission's list
of Corporate Officials.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. The Respondent's
answer and all interventions, or protests must be filed on or before
the comment date. The Respondent's answer, motions to intervene, and
protests must be served on the Complainants.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov. Persons unable to file electronically should submit an
original and 5 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street NE, Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the
``eLibrary'' link and is available for electronic review in the
Commission's Public Reference Room in Washington, DC. There is an
``eSubscription'' link on the website that enables subscribers to
receive email notification when a document is added to a subscribed
docket(s). For assistance with any FERC Online service, please email
[email protected], or call<PHONE_NUMBER> (toll free). For
TTY, call<PHONE_NUMBER>.
    Comment Date: 5:00 p.m. Eastern Time on August 13, 2018.

    Dated: July 25, 2018.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2018-16357 Filed 7-30-18; 8:45 am]
 BILLING CODE 6717-01-P


[Federal Register Volume 81, Number 207 (Wednesday, October 26, 2016)]
[Notices]
[Pages 74416-74417]
[FR Doc No: 2016-25876]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings #1

    Take notice that the Commission received the following electric
corporate filings:

    Docket Numbers: EC16-187-000.
    Applicants: Quantum Pasco Power, LP, Rockland Pasco Holdings, LLC.
    Description: Supplement to September 23, 2016 Joint Application of
Quantum Pasco Power, LP, et al. for Authorization of Disposition of
Jurisdictional Facilities Under Section 203 of the FPA and Request for
Shortened Notice Period.
    Filed Date: 10/17/16.
    Accession Number: 20161017-5065.
    Comments Due: 5 p.m. ET 10/27/16.

    Docket Numbers: EC17-14-000.
    Applicants: Sunflower Wind Project, LLC.
    Description: Application for Disposition of Jurisdictional Assets
of Sunflower Wind Project, LLC.
    Filed Date: 10/17/16.
    Accession Number: 20161017-5144.
    Comments Due: 5 p.m. ET 11/7/16.

    Docket Numbers: EC17-15-000.
    Applicants: Cimarron Bend Wind Project I, LLC, Cimarron Bend
Assets, LLC.
    Description: Application for Disposition of Jurisdictional Assets
of Cimarron Bend Wind Project I, LLC, et al.
    Filed Date: 10/17/16.
    Accession Number: 20161017-5147.
    Comments Due: 5 p.m. ET 11/7/16.

    Docket Numbers: EC17-16-000.
    Applicants: Lindahl Wind Project, LLC.
    Description: Application for Authorization Under Section 203 of the
Federal Power Act, Request for Expedited Consideration and Confidential
Treatment of Lindahl Wind Project, LLC.
    Filed Date: 10/17/16.
    Accession Number: 20161017-5148.
    Comments Due: 5 p.m. ET 11/7/16.

    Docket Numbers: EC17-17-000.
    Applicants: Coram California Development, L.P.
    Description: Application for Disposition of Jurisdictional
Facilities, et al. of Coram California Development, L.P.
    Filed Date: 10/17/16.
    Accession Number: 20161017-5165.
    Comments Due: 5 p.m. ET 11/7/16.

    Docket Numbers: EC17-18-000.
    Applicants: TTK Power, LLC, Empire Generating Co, LLC.

    Description: Application under Section 203 of the Federal Power
Act, et al. of Empire Generating Co, LLC, et al.
    Filed Date: 10/18/16.
    Accession Number: 20161018-5110.
    Comments Due: 5 p.m. ET 11/8/16.

    Take notice that the Commission received the following exempt
wholesale generator filings:

    Docket Numbers: EG17-14-000.
    Applicants: ESS Rabbit Hill Project, LLC.
    Description: Notice of Self-Certification of Exempt Wholesale
Generator Status of ESS Rabbit Hill Project, LLC.
    Filed Date: 10/17/16.
    Accession Number: 20161017-5177.
    Comments Due: 5 p.m. ET 11/7/16.

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER10-2564-007; ER10-2600-007; ER10-2289-007.
    Applicants: Tucson Electric Power Company, UNS Electric, Inc.,
UniSource Energy Development Company.
    Description: Notification of Changes in Status of Tucson Electric
Power Company, et al.
    Filed Date: 10/17/16.
    Accession Number: 20161017-5179.
    Comments Due: 5 p.m. ET 11/7/16.

    Docket Numbers: ER10-2794-020; ER14-2672-005; ER12-1825-018.
    Applicants: EDF Trading North America, LLC, EDF Energy Services,
LLC, EDF Industrial Power Services (CA), LLC.
    Description: Notice of Non-Material Change in Status of EDF Trading
North America, LLC, et al.
    Filed Date: 10/17/16.
    Accession Number: 20161017-5178.
    Comments Due: 5 p.m. ET 11/7/16.

    Docket Numbers: ER16-1483-004.
    Applicants: California Independent System Operator Corporation.
    Description: Compliance filing: 2016-10-17 Compliance Filing with
Sept. 16 Order Frequency Response to be effective 8/15/2016.
    Filed Date: 10/17/16.
    Accession Number: 20161017-5138.
    Comments Due: 5 p.m. ET 11/7/16.

    Docket Numbers: ER17-114-001.
    Applicants: California Independent System Operator Corporation.
    Description: Compliance filing: 2016-10-17 Errata to Order 827
Order 828 Compliance Filing to be effective 9/21/2016.
    Filed Date: 10/17/16.
    Accession Number: 20161017-5141.
    Comments Due: 5 p.m. ET 11/7/16.

    Docket Numbers: ER17-131-000.
    Applicants: Pacific Gas and Electric Company.
    Description: Sec.  205(d) Rate Filing: Quarterly Filing of City and
County of San Francisco's WDT SA 275 for Q3 2016 to be effective 9/30/
2016.
    Filed Date: 10/18/16.
    Accession Number: 20161018-5000.
    Comments Due: 5 p.m. ET 11/8/16.

    Docket Numbers: ER17-132-000.
    Applicants: Portland General Electric Company.
    Description: Sec.  205(d) Rate Filing: PGE11 MBR Sec 6 waiver
revision to be effective 8/29/2016.
    Filed Date: 10/18/16.
    Accession Number: 20161018-5002.
    Comments Due: 5 p.m. ET 11/8/16.

    Docket Numbers: ER17-133-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: ISA No. 4541, Queue W1-124/
AA2-049, Notice of Cancellation of 2840, 2926, 3061 to be effective 5/
10/2011.
    Filed Date: 10/18/16.
    Accession Number: 20161018-5054.
    Comments Due: 5 p.m. ET 11/8/16.

    Docket Numbers: ER17-134-000.
    Applicants: American Transmission Systems, Incorporation, PJM
Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: American Transmission
Systems, Inc. Submits ECSA No. 4553 to be effective 12/9/2016.
    Filed Date: 10/18/16.
    Accession Number: 20161018-5105.
    Comments Due: 5 p.m. ET 11/8/16.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: October 18, 2016.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2016-25876 Filed 10-25-16; 8:45 am]
BILLING CODE 6717-01-P


EPA REGISTRATION DIVISION COMPANY NOTICE OF FILING FOR PESTICIDE PETITIONS PUBLISHED IN THE FEDERAL REGISTER

EPA Registration Division contact: [P.V. Shah,<PHONE_NUMBER>]

INSTRUCTIONS:  Please utilize this outline in preparing the pesticide petition.  In cases where the outline element does not apply, please insert "NA-Remove" and maintain the outline. Please do not change the margins, font, or format in your pesticide petition. Simply replace the instructions that appear in green, i.e., "[insert company name]," with the information specific to your action

[Joint Inerts Task Force, Cluster Support Team 2 (JITF CST2)]

[2E8092]

	EPA has received a pesticide petition (2E8092) from [Joint Inerts Task Force, Cluster Support Team 2, EPA Company Number 84914], [c/o Huntsman Corp., 8600 Gosling Rd., The Woodlands, TX  77381] proposing, pursuant to section 408(d) of the Federal Food, Drug, and Cosmetic Act (FFDCA), 21 U.S.C. 346a(d), to amend 40 CFR part 180.

To amend existing exemptions from the requirement of a tolerance [by adding Chemical Abstracts Service Registry Numbers (CASRNs) for post-harvest use on agricultural crops under 40 CFR §180.910 and when applied to animals under 40 CFR §180.930 for the following two chemistry descriptors that are used as surfactants not to exceed 30% of pesticide formulation: Alkyl Alcohol Alkoxylate Phosphate and Sulfate Derivatives (AAAPD and AAASD respectively), including:

AAAPD Surfactants:

40 CFR §180.910 and §180.930: α-Alkyl (minimum C6 linear or branched, saturated and or unsaturated)-ω-hydroxypolyoxyethylene polymer with or without polyoxypropylene, mixture of di- and monohydrogen phosphate esters and the corresponding ammonium, calcium, magnesium, monoethanolamine, potassium, sodium, and zinc salts of the phosphate esters; minimum oxyethylene content averages 2 moles; minimum oxypropylene content is 0 moles; used as surfactants not to exceed 30% of pesticide formulation.

                                     CASRN
                              AAAPD Chemical Name
                                  103170-31-6
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C8-10-alkyl ethers, phosphates, potassium salts
                                  103170-32-7
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, monococo alkyl ethers, phosphates, potassium salts
                                  106233-09-4
                   Alcohols, C16-18, ethoxylated, phosphates
                                  106233-10-7
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C12-20-alkyl ethers, phosphates
                                 1072943-56-6
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C11-14-isoalkyl ethers, C13-rich, phosphates, sodium salts
                                  110392-49-9
            Alcohols, C9-11, ethoxylated, phosphated, sodium salt
                                  111798-26-6
   Poly(oxy-1,2-ethanediyl), a-(2-ethylhexyl)-w-hydroxy-, phosphate, Na salt
                                  111905-50-1
           Alcohols C16-18, ethoxylated, phosphated, potassium salt
                                  116671-23-9
Poly(oxy-1,2-ethanediyl), a,a'-phosphinicobis[w-hydroxy-, di-C12-14-alkyl ethers, sodium salts
                                  117584-36-8
Poly(oxy-1,2-ethanediyl), a,a'-phosphinicobis[w-hydroxy-, di-C12-15-alkyl ethers
                                 1187742-89-7
    Alcohols C16-18 and C18 unsatured, ethoxylated (2 EO), phosphate salt
                                 1187743-35-6
   Alcohols, C16-18 and C18-unsatd., ethoxylated, phosphate, potassium salt
                                  119415-05-3
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C16-20-alkyl ethers, phosphates, sodium salts
                                  121158-61-0
Poly(oxy-1,2-ethanediyl), a,a'-phosphinicobis[w-hydroxy-, di-C12-14-alkyl ethers
                                  121158-63-2
    Poly(oxy-1,2-ethanediyl), a-phosphono-w-hydroxy-, C12-14-alkyl ethers
                                  125139-13-1
     Poly(oxy-1,2-ethanediyl), a-phosphono-w-hydroxy-, C14-18-alkyl ethers
                                  125301-86-2
     Poly(oxy-1,2-ethanediyl), a-phosphono-w-hydroxy-, C6-10-alkyl ethers
                                  125301-87-3
Poly(oxy-1,2-ethanediyl), a-phosphono-w-hydroxy-, C10-14-alkyl ethers, potassium salts
                                  126646-03-5
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C10-14-alkyl ethers, phosphates, potassium salts
                                  129870-77-5
Oxirane, methyl-, polymer with oxirane, mono(C13-15-branched and linear alkyl) ethers, phosphates
                                  129870-80-0
Poly(oxy-1,2-ethanediyl), a-phosphono-w-hydroxy-, C10-14-alkyl ethers, disodium salts
                                  130354-37-9
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C12-13-alkyl ethers, phosphates, sodium salts
                                  136504-88-6
Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, mono-C9-11-alkyl ethers, phosphates
                                  143372-50-3
Poly(oxy-1,2-ethanediyl), a,a'-phosphinicobis[w-hydroxy-, di-C13-15-alkyl ethers, ammonium salts
                                  143372-51-4
Poly(oxy-1,2-ethanediyl), a-phosphono-w-hydroxy-, C13-15-alkyl ethers, diammonium salts
                                  154518-40-8
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono(C10-rich C9-11-isoalkyl) ethers, phosphates, potassium salts
                                  155240-11-2
Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, mono-C12-18-alkyl ethers, phosphates
                                  160498-49-7
Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, mono-C13-15-alkyl ethers, phosphates, ammonium salts
                                  160611-24-5
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, monotallow alkyl ethers, phosphates, sodium salts
                                  171543-66-1
    Poly(oxy-1,2-ethanediyl), a,a'-phosphinicobis[w-(hexyloxy)-, NH4 salt
                                  210493-60-0
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mixed mono-C16-20-isoalkyl & monotallow alkyl ethers, phosphates, Na salts
                                  246159-55-7
Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, mono-C12-16-alkyl ethers, phosphates
                                  251298-11-0
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C16-18-alkyl ethers, phosphates, sodium salts
                                  261627-68-3
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C11-14-isoalkyl ethers, C13-rich, phosphates, potassium salts
                                  26982-05-8
         Poly(oxy-1,2-ethanediyl), a,a'-phosphinicobis[w-(dodecyloxy)-
                                  31800-89-2
          Poly(oxy-1,2-ethanediyl), a,a'-phosphinicobis[w-(octyloxy)-
                                  39341-09-8
          Poly(oxy-1,2-ethanediyl), a,a'-phosphinicobis[w-(decyloxy)-
                                  39341-65-6
     Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, 2-ethylhexyl phosphate
                                  39464-69-2
   Poly(oxy-1,2-ethanediyl), a-(9Z)-9-octadecen-1-yl-w-hydroxy-, phosphate
                                  422563-19-7
Poly(oxy-1,2-ethanediyl), a-(2-ethylhexyl)-w-hydroxy-, phosphate, ammonium salt
                                  50668-50-3
Poly(oxy-1,2-ethanediyl), a,a'-phosphinicobis[w-(dodecyloxy)-, potassium salt (1:1)
                                  51884-64-1
          Poly(oxy-1,2-ethanediyl), a,a'-phosphinicobis[w-(hexyloxy)-
                                  57486-09-6
Poly(oxy-1,2-ethanediyl), a-9-octadecenyl-w-hydroxy-, (Z)-, phosphate, sodium salt
                                  59112-71-9
Poly(oxy-1,2-ethanediyl), a-(9Z)-9-octadecen-1-yl-w-hydroxy-, phosphate, potassium salt
                                  62362-49-6
         Poly(oxy-1,2-ethanediyl), a-octadecyl-w-hydroxy-, phosphate
                                  63747-86-4
    Oxirane, 2-methyl-, polymer with oxirane, monododecyl ether, phosphate
                                  63887-55-8
Poly(oxy-1,2-ethanediyl), a,a'-phosphinicobis[w-(decyloxy)-, potassium salt (1:1)
                                  66272-25-1
         Poly(oxy-1,2-ethanediyl), a-isododecyl-w-hydroxy-, phosphate
                                  67786-06-5
Poly(oxy-1,2-ethanediyl), a-phosphono-w-[(2-ethylhexyl)oxy]-, potassium salt (1:2)
                                  67989-06-4
           Poly(oxy-1,2-ethanediyl), a-hexyl-w-hydroxy-, phosphate
                                  68071-37-4
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C12-15-alkyl ethers, phosphates, potassium salts
                                  68130-44-9
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C12-13-alkyl ethers, phosphates, potassium salts
                                  68130-45-0
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C12-13-alkyl ethers, phosphates
                                  68130-46-1
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C12-13-alkyl ethers, phosphates, magnesium salts
                                  68186-29-8
    Poly(oxy-1,2-ethanediyl), a-tridecyl-w-hydroxy-, phosphate, sodium salt
                                  68186-34-5
Poly(oxy-1,2-ethanediyl), a-[(9Z)-1-oxo-9-octadecen-1-yl]-w-hydroxy-, phosphate, sodium salt
                                  68238-84-6
Poly(oxy-1,2-ethanediyl), a-(2-ethylhexyl)-w-hydroxy-, phosphate, potassium salt
                                  68311-04-6
 Poly(oxy-1,2-ethanediyl), a-phosphono-w-(tridecyloxy)-, potassium salt (1:2)
                                  68389-72-0
      Poly(oxy-1,2-ethanediyl), a-(sec-pentadecyl)-w-hydroxy-, phosphate
                                  68413-78-5
  Poly(oxy-1,2-ethanediyl), a,a'-phosphinicobis[w-[(1-methyltetradecyl)oxy]-
                                  68425-75-2
Ethanol, 2-amino-, polymer with a-tridecyl-w-hydroxypoly(oxy-1,2-ethanediyl) phosphate
                                  68439-39-4
       Poly(oxy-1,2-ethanediyl), a-(2-ethylhexyl)-w-hydroxy-, phosphate
                                  68511-15-9
Oxirane, 2-methyl-, polymer with oxirane, monodecyl ether, phosphate, sodium salt
                                  68511-36-4
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C11-15-alkyl ethers, phosphates
                                  68551-05-3
Oxirane, 2-methyl-, polymer with oxirane, mono-C10-12-alkyl ethers, phosphates
                                  68585-15-9
 Oxirane, 2-methyl-, polymer with oxirane, mono-C6-10-alkyl ethers, phosphates
                                  68585-16-0
Oxirane, 2-methyl-, polymer with oxirane, mono-C6-10-alkyl ethers, phosphates, potassium salts
                                  68585-17-1
Oxirane, 2-methyl-, polymer with oxirane, mono-C6-10-alkyl ethers, phosphates, sodium salts
                                  68585-39-7
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C8-10-alkyl ethers, phosphates, sodium salts
                                  68603-24-7
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, monococo alkyl ethers, phosphates, ammonium salts
                                  68607-14-7
Polyphosphoric acids, esters with polyethylene glycol mono-C11-15-sec-alkyl ethers
                                  68610-64-0
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C16-22-alkyl ethers, phosphates, sodium salts
                                  68649-30-9
Oxirane, 2-methyl-, polymer with oxirane, mono-C12-18-alkyl ethers, phosphates
                                  68650-84-0
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C11-15-alkyl ethers, phosphates, potassium salts
                                  68855-46-9
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C11-15-sec-alkyl ethers, phosphates, sodium salts
                                  68856-03-1
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C10-15-sec-alkyl ethers, phosphates
                                  68890-90-4
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C11-15-branched alkyl ethers, phosphates, potassium salts
                                  68890-91-5
Oxirane, 2-methyl-, polymer with oxirane, mono-C10-12-alkyl ethers, phosphates, potassium salts
                                  68891-12-3
Oxirane, 2-methyl-, polymer with oxirane, mono-C10-16-alkyl ethers, phosphates, sodium salts
                                  68891-26-9
   Poly(oxy-1,2-ethanediyl), a,a'-phosphinicobis[w-(tridecyloxy)-, branched
                                  68909-65-9
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C10-16-alkyl ethers, phosphates
                                  68909-67-1
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono(C8-18 and C18-unsatd. alkyl) ethers, phosphates
                                  68909-69-3
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C11-13-branched alkyl ethers, phosphates
                                  68921-24-4
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C6-12-alkyl ethers, phosphate
                                  68921-60-8
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C11-15-sec-alkyl ethers, phosphates
                                  68954-87-0
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C10-16-alkyl ethers, phosphates, potassium salts
                                  68954-88-1
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C12-20-alkyl ethers, phosphates, sodium salts
                                  68954-92-7
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C11-13-branched alkyl ethers, phosphates, potassium salts
                                  68987-35-9
          Poly(oxy-1,2-ethanediyl), a-eicosyl-w-hydroxy-, phosphate
                                  69029-43-2
   Poly(oxy-1,2-ethanediyl), a-tridecyl-w-hydroxy-, phosphate, ammonium salt
                                  69980-69-4
   Poly(oxy-1,2-ethanediyl), a-octadecyl-w-hydroxy-, phosphate, sodium salt
                                  70247-99-3
Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, mono-C4-18-alkyl ethers, phosphates, potassium salts
                                  70248-14-5
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C6-10-alkyl ethers, phosphates
                                  70903-63-8
   Poly(oxy-1,2-ethanediyl), a-hexadecyl-w-hydroxy-, phosphate, sodium salt
                                  71965-23-6
Oxirane, 2-methyl-, polymer with oxirane, mono(dihydrogen phosphate), tridecyl ether
                                  71965-24-7
Oxirane, 2-methyl-, polymer with oxirane, mono(dihydrogen phosphate), tridecyl ether, dipotassium salt
                                  72480-27-4
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C9-16-alkyl ethers, phosphates
                                  72623-67-7
Oxirane, 2-methyl-, polymer with oxirane, mono(dihydrogen phosphate), 2-ethylhexyl ether
                                  72623-68-8
Oxirane, 2-methyl-, polymer with oxirane, hydrogen phosphate (2:1), bis(2-ethylhexyl) ether
                                  72828-56-9
Poly(oxy-1,2-ethanediyl), a,a'-phosphinicobis[w-hydroxy-, di-C12-14-alkyl ethers, potassium salts
                                  72828-57-0
Poly(oxy-1,2-ethanediyl), a-phosphono-w-hydroxy-, C12-14-alkyl ethers, dipotassium salts
                                  73018-34-5
    Poly(oxy-1,2-ethanediyl), a-octyl-w-hydroxy-, phosphate, potassium salt
                                  73050-08-5
Poly(oxy-1,2-ethanediyl), a,a'-phosphinicobis[w-hydroxy-, di-C13-15-alkyl ethers, sodium salts
                                  73050-09-6
Poly(oxy-1,2-ethanediyl), a-phosphono-w-hydroxy-, C13-15-alkyl ethers, disodium salts
                                  73361-29-2
    Oxirane, methyl-, polymer with oxirane, monohexadecyl ether, phosphate
                                  73378-71-9
Poly(oxy-1,2-ethanediyl), a,a'-phosphinicobis[w-hydroxy-, di-C9-11-alkyl ethers, sodium salts
                                  73378-72-0
Poly(oxy-1,2-ethanediyl), a-phosphono-w-hydroxy-, C9-11-alkyl ethers, disodium salts
                                  73559-42-9
Poly(oxy-1,2-ethanediyl), a,a'-phosphinicobis[w-hydroxy-, di-C10-20-alkyl ethers
                                  73559-43-0
Poly(oxy-1,2-ethanediyl), a,a'-phosphinicobis[w-hydroxy-, di-C10-20-alkyl ethers, potassium salts
                                  73559-44-1
Poly(oxy-1,2-ethanediyl), a-phosphono-w-hydroxy-, C10-20-alkyl ethers, dipotassium salts
                                  73559-45-2
     Poly(oxy-1,2-ethanediyl), a-phosphono-w-hydroxy-, C10-20-alkyl ethers
                                  74499-76-6
Poly(oxy-1,2-ethanediyl), a,a'-phosphinicobis[w-(tridecyloxy)-, potassium salt (1:1)
                                  76930-25-1
  Phosphoric acid, mono- and di-C12-18 alkyl ester, sodium salt, ethoxylated
                                  78330-22-0
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C11-14-isoalkyl ethers, C13-rich, phosphates, ethoxylated
                                   9004-80-2
             Poly(oxy-1,2-ethanediyl), a-phosphono-w-(decyloxy)-
                                  91254-26-1
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono(C16 and C18-unsatd. alkyl) ethers, phosphates
                                  93925-54-3
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, monococo alkyl ethers, phosphates, sodium salts
                                  96416-89-6
Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C11-15-sec-alkyl ethers, phosphates, potassium salts

AAASD Surfactants:

40CFR 180.910 and 180.930:  α-Alkyl(C6-C15)-ω-hydroxypoly(oxyethylene) sulfate, and its ammonium, calcium, magnesium, potassium, sodium, and zinc salts, poly(oxyethylene) content averages 2-4 moles; used as surfactants not to exceed 30% of pesticide formulation.

                                     CASRN
                              AAASD Chemical Name
                                  106597-03-9
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C13-15-branched alkyl ethers, sodium salts
                                  110392-50-2
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C12-13-alkyl ethers, sodium salts
                                  125301-88-4
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C12-14-alkyl ethers, ammonium salts
                                  125301-89-5
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C12-15-alkyl ethers, ammonium salts
                                  125301-92-0
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C12-15-alkyl ethers, sodium salts
                                  125736-54-1
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C12-14-sec-alkyl ethers, sodium salts
                                  157707-85-2
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C6-12-alkyl ethers, sodium salts
                                  160104-51-8
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C12-14-alkyl ethers, magnesium salts
                                  160901-27-9
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C9-11-branched and linear alkyl ethers, ammonium salts
                                  160901-28-0
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C9-11-branched and linear alkyl ethers, sodium salts
                                  160901-29-1
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C11-14-branched and linear alkyl ethers, sodium salts
                                  160901-30-4
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C9-15-alkyl ethers, sodium salts
                                  161025-28-1
             Alcohols, C6-12, ethoxylated, sulfates, sodium salts
                                  161074-79-9
  Alcohols, C12-13, branched and linear, ethoxylated, sulfates, sodium salts
                                  162063-19-6
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C13-15-branched and linear alkyl ethers, sodium salts
                                  27140-00-7
   Ethanol, 2-[2-(dodecyloxy)ethoxy]-, 1-(hydrogen sulfate), ammonium salt
                                  27731-61-9
  Poly(oxy-1,2-ethanediyl), a-sulfo-w-(tetradecyloxy)-, ammonium salt (1:1)
                                  27731-62-0
    Poly(oxy-1,2-ethanediyl), a-sulfo-w-(tetradecyloxy)- sodium salt (1:1)
                                  34431-25-9
      Poly(oxy-1,2-ethanediyl), a-sulfo-w-(octyloxy)-, sodium salt (1:1)
                                  35015-74-8
   Poly(oxy-1,2-ethanediyl), a-sulfo-w-(pentadecyloxy)-, sodium salt (1:1)
                                  52286-18-7
     Poly(oxy-1,2-ethanediyl), a-sulfo-w-(octyloxy)-, ammonium salt (1:1)
                                  52286-19-8
        Poly(oxy-1,2-ethanediyl), a-sulfo-w-(decyloxy)-, ammonium salt
                                  54116-08-4
        Poly(oxy-1,2-ethanediyl), a-sulfo-w-(tridecyloxy)-, sodium salt
                                  61702-79-2
    Poly(oxy-1,2-ethanediyl), a-sulfo-w-(tridecyloxy)-, ammonium salt (1:1)
                                  63428-86-4
     Poly(oxy-1,2-ethanediyl), a-sulfo-w-(hexyloxy)-, ammonium salt (1:1)
                                  63428-87-5
      Poly(oxy-1,2-ethanediyl), a-sulfo-w-(decyloxy)-, sodium salt (1:1)
                                  65086-57-9
                Poly(oxy-1,2-ethanediyl), a-sulfo-w-(decyloxy)-
                                  65086-79-5
             Poly(oxy-1,2-ethanediyl), a-sulfo-w-(tetradecyloxy)-
                                  67674-66-2
             Poly(oxy-1,2-ethanediyl), a-sulfo-w-(pentadecyloxy)-
                                  67845-82-3
                Poly(oxy-1,2-ethanediyl), a-sulfo-w-(octyloxy)-
                                  67845-83-4
     Poly(oxy-1,2-ethanediyl), a-sulfo-w-(pentadecyloxy)-, ammonium salt
                                  68037-05-8
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C6-10-alkyl ethers, ammonium salts
                                  68037-06-9
       Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C6-10-alkyl ethers
                                  68171-41-5
                Poly(oxy-1,2-ethanediyl), a-sulfo-w-(hexyloxy)-
                                  68610-66-2
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C10-12-alkyl ethers, sodium salts
                                  68649-53-6
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C12-13-alkyl ethers, ammonium salts
                                  68890-88-0
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C10-12-alkyl ethers, ammonium salts
                                  68891-29-2
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C8-10-alkyl ethers, ammonium salts
                                  68891-30-5
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C11-15-branched alkyl ethers, ammonium salts
                                  69011-37-6
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C8-14-alkyl ethers, ammonium salts
                                  75422-21-8
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C6-12-alkyl ethers, ammonium salts
                                  78330-17-3
    Poly(oxy-1,2-ethanediyl), a-sulfo-w-(hexyloxy)-, branched, sodium salt
                                  78330-16-2
   Poly(oxy-1,2-ethanediyl), a-sulfo-w-(hexyloxy)-, branched, ammonium salt
                                  78330-25-3
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C7-9-isoalkyl ethers, C8-rich, ammonium salts
                                  78330-26-4
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C9-11-isoalkyl ethers, C10-rich, ammonium salts
                                  78330-27-5
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C11-14-isoalkyl ethers, C13-rich, ammonium salts
                                  78330-28-6
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C7-9-isoalkyl ethers, C8-rich, sodium salts
                                  78330-29-7
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C9-11-isoalkyl ethers, C10-rich, sodium salts
                                  78330-30-0
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C11-14-isoalkyl ethers, C13-rich, sodium salts
                                   9021-91-4
  Poly[oxy(methyl-1,2-ethanediyl)], a-sulfo-w-(octyloxy)-, sodium salt (1:1)
                                  96130-61-9
Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C9-11-alkyl ethers, sodium salts

in or on all raw agricultural commodities.  [Prior to the submission of this petition to add missing CASRNs, Petition PP 9E7533 (Document ID EPA-HQ-OPP-2009-0131) was submitted to the Agency and these CASRNs were missing from the petition.  JITF CST2 is relying on the information submitted in 9E7533 to support this petition which includes the exact same chemistries.  JITF CST2 does not expect the addition of these CASRNs to result in additional exposure or risk.]  EPA has determined that the petition contains data or information regarding the elements set forth in section 408 (d)(2) of  FFDCA; however, EPA has not fully evaluated the sufficiency of the submitted data at this time or whether the data supports granting of the petition. Additional data may be needed before EPA rules on the petition.

A. Residue Chemistry

      1. Plant metabolism.	[Not Applicable]

	2. Analytical method. [Not Applicable]

	3. Magnitude of residues. [There is no specific crop residue information available for AAAPD and AAASD and this information is typically not available nor required for the establishment of a tolerance exemption for inert ingredients.]

B. Toxicological Profile

1. Acute toxicity.  [AAAPD and AAASD are likely skin/eye irritants in their undiluted forms, but not acutely toxic. The reported oral LD50 values were higher than 1,600 mg/kg for the alkyl ether phosphates C13EO3,6,12P, CASRN 9046-01-9 and alkyl ether sulfates NaC12EO3S, CASRN 9004-82-4 (Category III).  No effects were found at any of the concentrations tested dermally.]

	2. Genotoxicity. [NaC12-15EO2-3S compounds were not mutagenic in bacterial or mammalian in vitro cell systems or in vivo (HERA 2003).  Neither IARC, NTP nor OSHA listed as a carcinogen.]

	3. Reproductive and developmental toxicity. [One representative compound for the group of chemicals requested in 9E7533  (and 2E8092) is CASRN 68891-38-3 Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C12-14-alkyl ethers, sodium salts.  The studies with the sulfate derivatives (AAASD) showed little to no toxicity in the dams or the pups, with the NOEL in a developmental toxicity study in rats with CASRN 68891-38-3 at the limit dose of 1000 mg/kg/day, and a reproductive NOAEL of 0.3% in drinking water, equivalent to 300 mg/kg/day, the highest dose tested, in a two-generation reproduction study with CASRN 68891-38-3).

CASRN 68891-38-3 was evaluated for effects on the reproduction and prenatal/postnatal development of the rat when administered orally via the drinking water through two successive generations.  No reproductive or developmental effects were observed at any dose, even where corresponding parental toxicity was observed.  The NOAEL for reproductive effects was 0.3% in drinking water, equivalent to 300 mg/kg/day, the highest dose tested.

In studies with the phosphate derivatives (AAAPD), the reproductive/developmental NOEL for the OECD 422 study with CASRN 68130-47-2 was 800 mg/kg/day, the highest dose tested, and for CASRN 78330-24-2 the NOEL was 200 mg/kg/day.

	4. Subchronic toxicity. [Based on the Federal Register Notice (August 9, 2006, Volume 71, Number 153, pages 45415-45424), the Agency stated that the preferred test for repeat-dose toxicity is the "Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test (OECD Test Guideline 422)."
AAAPD (CASRN  68130-47-2 and CASRN 78330-24-2) have been tested in repeat dose studies (OECD 422 Combined Repeated Dose Toxicity Study with a Reproduction/Developmental Toxicity Screening Test).  The paternal and maternal NOAEL for CASRN 68130-47-2 was 200 mg/kg/day.  The paternal and maternal no-observable-effect-level (NOEL) for CASRN 78330-24-2 was 200 mg/kg/day.  The NOAEL of 200 mg/kg/day was selected as the toxicology endpoint for the chronic risk assessment for the phosphate derivatives (AAAPD).

Subchronic data have been found in the public domain for the AAASD.   Subchronic 21-day repeat dose dietary studies showed low toxicity of compounds with carbon lengths of C12-15, C12-14 and C13-15 with sodium or ammonium alkyl ethoxylates with POE n=3.  One study indicated that C16-18 POE n=18 had comparable low toxicity.  No-observed-adverse-effect levels (NOAELs) range from 120 to 468 mg/kg/day, similar to a NOAEL from a 90-day rat gavage study with NaC12-14 POE n=2(CASRN 68891-38-3), which was reported to be 225 mg/kg/day.  In addition, another 90-day repeat dose dietary study with NaC12-15 POE n=3(CASRN 68424-50-0) resulted in low toxicity, with a NOAEL of greater than approximately 50 mg/kg/day (calculated based on dose of 1000 ppm in diet).  Effects were usually related to hepatic hypertrophy, increased liver weight, and related increases in hematological endpoints related to liver enzyme induction.

Henkel KgaA (1994a) evaluated CASRN 68891-38-3 for systemic toxicity in Wistar (Hsd/Win:WU) rats by gavage at doses of 0, 25, 75, and 225 mg/kg/day for 90-days.  No treatment related symptoms including changes in mean food consumption or water intake, total body weight gain, hematological examinations, clinical chemistry, absolute and relative organ weights and macroscopical examinations were observed in any group.   According to systemic, behavioral, and clinical abnormalities the NOAEL of 225 mg/kg/day for sodium lauryl ether sulfate was determined.

CASRN 68891-38-3 was evaluated for effects on the reproduction and prenatal/postnatal development of the rat when administered orally via the drinking water through two successive generations. Based on this study an overall no-observed-adverse-effect level (NOAEL) for systemic effects was 0.1%, which was 86.6 mg/kg/day for the F0 generation, and 149.5 mg/kg/day for the F1 generation. The NOAEL of 86.6 mg/kg/day was selected as the toxicology endpoint for the chronic risk assessment for the sulfate derivatives (AAASD).]

	5. Chronic toxicity [Based on the Federal Register Notice (August 9, 2006, Volume 71, Number 153, pages 45415-45424), the Agency stated that the preferred test for repeat-dose toxicity is the "Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test (OECD Test Guideline 422)."

Chronic dietary studies conducted with rats on AAASDs showed no incidence of cancer and no effects at the concentrations tested (lowest dose tested was ca 75 mg/kg/day).]

	6. Animal metabolism. [The mammalian metabolic pathway for AAASD type surfactants has been published.  The mammalian metabolic pathway for AAASD type surfactants has been published (HERA, 2003). For compounds of comparable C16 carbon chain, the metabolites of the lower molecular weight ethoxylated (POE n=3) AAASD surfactants are readily absorbed and excreted primarily in the urine whereas for the C16 AAASD surfactants with increased ethoxylation (POE n=9) are poorly absorbed and excreted primarily in the feces (McDermott et al., 1975).   There was also no evidence of hydrolysis of the sulfate group from C16 POE n= 3 and C16 POE n=9 or of metabolism of the ethoxylate portion of the molecule.  With C11 POE n=3 and C12 POE n=3 metabolic studies in rats confirmed that the alkyl chain is extensively metabolized by beta- or omega-oxidation leaving the ethoxysulfate, which is excreted directly (Taylor et al., (1978)

By analogy to what would generally be expected in the metabolism for phosphate esters, the AAAPD surfactants may initially undergo metabolism to generate the corresponding AAA and POE (or POE/POP) phosphate glycol.  By analogy to the reported metabolism for the CST1 Alkyl Alkoxylate Alcohol (AAA) surfactants, the dephosphoralyted metabolite should be hydrolyzed to the POE (or POE/POP) polyalkoxylate glycols and linear branched saturated and unsaturated alkyl alcohol metabolites.  The resultant alkyl alcohol metabolites would be oxidized in fatty acid oxidation pathways.  The polyalkoxylate glycols may either be conjugated and excreted unchanged or hydrolyzed/oxidized to various degraded metabolites before being conjugated and excreted.]

	7. Metabolite toxicology. [No metabolites of toxicological concern are expected based on the proposed animal metabolic pathway.]

	8. Endocrine disruption. [The AAAPD and AAASD surfactants do not belong to a class of chemicals known or suspected of having adverse effects on the estrogen receptor or endocrine system.  AAAPD and AAASD have been evaluated in acute, subchronic, developmental and reproductive studies capable of detecting effects on endocrine mediated events. The results of these studies did not give any indication of a treatment-related effect on the estrogen receptor or endocrine system.]

C. Aggregate Exposure

       1. Dietary exposure. [The dietary (food plus drinking water) exposures for AAAPD and AAASD surfactants are expressed as a percentage of the proposed chronic population adjusted dose (cPAD) for the general US population and children 1-2 years old, the subpopulation with the highest potential exposures.

 Based on I-DEEM screening level calculations, the chronic dietary exposures for the AAAPD are estimated to be 6% of the cPAD for the general U.S. population and 21% of the cPAD for children 1-2 years old.

 Based on I-DEEM screening level calculations, the chronic dietary exposures for the AAASD are estimated to be 14% of the cPAD for the general U.S. population and 49% of the cPAD for children 1-2 years old.

 These data demonstrate that the I-DEEM screening level chronic dietary (food and drinking water) exposures for both the AAAPD and AAASD are well below 100% of the cPAD, and are therefore below EPA's established level of concern for all U.S. subpopulations.

On the basis of the OECD 422 repeat dose toxicity study and comparison of I-DEEM exposures to the proposed cPAD, the JITF CST2 asserts that there is sufficient basis for EPA to grant a tolerance exemption for these additional AAAPD and AAASD surfactant CASRNs.

CHRONIC DIETARY SAFETY ASSESSMENT, % cPAD

                                     Study
                           Chronic Systemic NOAEL 1
                                 mg/kg bw/day
                                    cPAD[2]
                                 mg/kg bw/day
                                Percent  cPAD
                           Children 1-2 years of age
                                 Percent cPAD
                              U.S. Gen Population
AAAPD CASRN 68130-47-2  and CASRN 78330-24-2; Repeated Dose Toxicity with Reproduction/
Developmental Toxicity Screening in Rats- (OECD 422)

AAASD Sulfate CASRN 68891-38-3;  systemic toxicity endpoint for repeated dose from the two generation rat reproductive drinking water study

200

87
                                      2.0

                                     0.87
                                      21%

                                      49%
                                      6%

                                      14%
 Note:
 [1] NOAEL  -  No observed adverse effect level
 [2] cPAD  -  Chronic population adjusted dose, defined as:  chronic NOAEL / (safety factor  FQPA factor)

 i. Food. [The available data demonstrate that the I-DEEM screening level chronic dietary (food and drinking water) exposures are well below 100% of the cPAD, and are therefore below EPA's established level of concern for all U.S. subpopulations.]

	ii. Drinking water. [Drinking water is included in the I-DEEM exposure assessment. Exposure to AAAPD and AAASD via drinking water is expected to be negligible.]

	2. Non-dietary exposure. [AAAPD and AAASD surfactants are used as inert ingredients in agricultural formulations as well as in non-pesticidal uses such as, personal care products household cleaning products and laundry detergents. Given the low estimate of dietary exposure, there is ample room in the overall aggregate MOE for non-dietary uses.]

D. Cumulative Effects

	[For the purpose of the tolerance exemption actions cited herein, the JITF CST2 has assumed that the AAAPD and AAASD will not have a common mechanism of toxicity with other surfactant substances. It is therefore appropriate to consider only the potential risks of the compounds included in CST2 in the exposure assessment.]

E. Safety Determination

      1. U.S. population. [A dietary exposure assessment using current EPA inert screening level methodology (I-DEEM) was conducted. Based on the conservative I-DEEM dietary exposure estimates, there is a reasonable certainty that no harm will result to the US population from the aggregate exposure to AAAPD and AAASD.]

      2. Infants and children. [The FFDCA Section 408 requires an additional tenfold margin of safety for the protection of infants and children in case of threshold effects to account for prenatal and postnatal toxicity, and an inadequate toxicity database.  Where an adequate and reliable database is available and there is a lack of evidence for increased susceptibility, the FQPA safety factor may be reduced or removed.  An evaluation of susceptibility and uncertainty issues associated with Anionic Alkyl Alkoxylate Derivatives has been performed.  Based on the points below, the JITF CST2 recommends that the FQPA safety factor be reduced from the default 10X to 1X.

* A scientifically sound mammalian toxicology database, which includes acute, subchronic, reproductive, and developmental toxicity data, indicates no adverse effects to sensitive populations.
* The AAAPD and AAASD surfactants do not belong to a class of chemicals known or suspected of having adverse effects on the estrogen receptor or endocrine system.  These surfactants have been evaluated in acute, subchronic, developmental and reproductive studies capable of detecting effects on endocrine mediated events.
* The AAASDs have also been evaluated in chronic studies including a two year dietary study (Moore 1983) and a two generation reproduction study with drinking water (Henkel KGaA 1999, MRID 470609903, 47112401).
* OECD 422 testing and other reproduction and developmental studies available in the literature (HERA, 2003) indicates no reproductive and no developmental effects in offspring at levels that are not maternally toxic.
* There was no evidence of effects on the nervous system in the acute, subchronic or reproduction studies.]

F. International Tolerances

	[There are no known international tolerances for Alkyl Alcohol Alkoxylate Phosphate and Sulfate Derivatives.]